ADIAL PHARMACEUTICALS, INC. Purchase Agreements
12 Contracts & Agreements
- Form of Securities Purchase Agreement, dated October 19, 2023, by and between Adial Pharmaceuticals, Inc. and the Purchaser signatory thereto (Filed With SEC on October 24, 2023)
- Purchase Agreement, dated as of May 31, 2023, by and between Adial Pharmaceuticals, Inc. and Alumni Capital LP (Filed With SEC on June 2, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 14, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 15, 2021)
- Amendment, dated January 25, 2021, by and among Adial Pharmaceuticals, Inc., Purnovate, Inc., a wholly owned subsidiary of Adial, PNV Conversion Corp. as successor-in interest to... (Filed With SEC on February 1, 2021)
- Equity Purchase Agreement, dated December 7, 2020, by and among Adial Pharmaceuticals, Inc., Purnovate, LLC, the members of Purnovate, LLC and Robert D. Thompson, as member... (Filed With SEC on December 10, 2020)
- Form of Securities Purchase Agreement, dated as of June 9, 2020, by and among Adial Pharmaceuticals, Inc. and the Investors (Filed With SEC on June 10, 2020)
- Securities Purchase Agreement dated June 6, 2018 (Filed With SEC on June 11, 2018)
- Form of Securities Purchase Agreement by and among Adial Pharmaceuticals, Inc. and certain investors (Filed With SEC on April 16, 2018)
- FORMOF SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2017)
- Securities Purchase Agreement dated as of May 1, 2017 by and between ADial Pharmaceuticals, LLC and FirstFire Global Opportunities Fund, LLC (Filed With SEC on September 7, 2017)